REQUEST A DEMO
Total
USD $0.00
Search more companies

Ali Raif Ilac A.S. (Turkiye)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ali Raif Ilac Sanayi Anonim Sirketi Profile Updated: March 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Aris, which was established under the name of Ali Raif ve Seriki in 1928, was reorganized in order to trade in pharmaceuticals industry by Muzaffer Turhan as of 1963. Since 1983 the company has had operations under the name of Ali Raif Ilac Sanayi A.S. While ARIS, which has principles of being respectful to people, trust, success and innovation in its operations ARIS, was marketing pharmaceuticals as a licensee of multinational companies in the early years of its foundation, it started to import final pharmaceuticals in 1986. Since 1990 it has started to produce and market equivalent pharmaceuticals and become one of the leading companies in Turkey.
Aris has nearly 150 pharmaceuticals that contribute in enhancing the quality of life thanks to their forms in therapeutic fields such as cardiovascular, diabetics, gastrointestinal, analgesic, anti-inflammatory, anti-flu, antiviral, antihistaminic, central nervous system.
After ARIS commenced equivalent pharmaceuticals licensing, production and marketing, export opportunities started to arise in parallel to them Philippines, Spain, Poland, Uzbekistan, Georgia, Azerbaijan, Moldova and EU countries are among the countries that they have export activities.

Headquarters
No:4 Yesilce Mahallesi Doga Sokak Kagithane
Istanbul; Marmara; Postal Code: 34418

Contact Details: Purchase the Ali Raif Ilac A.S. report to view the information.

Website: http://www.aliraif.com.tr

Basic Information
Total Employees:
Purchase the Ali Raif Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Ali Raif Ilac A.S. report to view the information.
Incorporation Date:
March 17, 1928
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Ali Raif Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
75.28%
Total operating revenue
75.28%
Operating profit (EBIT)
23.72%
Net Profit (Loss) for the Period
14.46%
Total assets
92.24%
Total equity
29.91%
Operating Profit Margin (ROS)
-6.6%
Net Profit Margin
-6.92%
Return on Equity (ROE)
-4.48%
Debt to Equity Ratio
42.55%
Quick Ratio
-0.67%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?